New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as oncology, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Astragalus and Schisandra tablets, Maiping tablets, Qianlie Antong tablets, Prosta Antong tablets, Gongliuning capsules, cough and phlegm granules, cold and flu granules, Wuhu San, Wei Funing capsules, and other proprietary Chinese medicine products. In addition, it engages in cultivation of Chinese herbal medicine; investment management; retail business; wholesale trading activities; and provision of resident services. The company was formerly known as Hengkang Medical Group Co.,Ltd. New Journey Health Technology Group Co.,LTD was founded in 2001 and is headquartered in Beijing, China.